ERBB2 and gastric cancer: Loganzo et al. reported that inhibition of upregulated ABC transporters causing ADC resistance allowed restoration of ado-trastuzumab emtansine sensitivity in HER2+ gastric cancer cells, which highlights the potential for alternate therapies to combat this drug resistance [103].